Apollo Speciality Hospital
Chennai, India
Hospital in Chennai, Tamil Nadu
Plot No, 64, Vanagaram-Ambattur Rd, Ayanambakkam, Ambattur Industrial Estate, Chennai, Tamil Nadu 600095
About Apollo Speciality Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Galapagos NV
3
Hoffmann-La Roche
3
Boehringer Ingelheim
2
Helsinn Healthcare SA
2
Pfizer
2
Daiichi Sankyo, Inc.
1
Eli Lilly and Company
1
Ferring Pharmaceuticals
1
Gilead Sciences
1
Millennium Pharmaceuticals, Inc.
1
Nereus Pharmaceuticals, Inc.
1
Clinical Trials at Apollo Speciality Hospital
During the past decade, Apollo Speciality Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on
average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
2006-03-01
2010-07-01
Completed
676
Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer
2008-02-01
2011-06-01
Completed
172
Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer
2010-03-01
2013-04-01
Completed
90
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
2011-04-01
Completed
1,455
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
2011-07-01
2012-11-01
Completed
743
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
2012-02-17
2019-11-14
Completed
258
An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
2018-12-05
2024-10-31
Recruiting
100
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Apollo Speciality Hospital" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Helsinn Healthcare SA" with 2 trials sponsored and "Pfizer"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Apollo Speciality Hospital"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Apollo Speciality Hospital
According to Clinical.Site data, the most researched conditions in "Apollo Speciality Hospital" are
"Breast Cancer" (3 trials), "Chemotherapy-Induced Nausea and Vomiting" (2 trials), "Crohn's Disease" (2 trials), "Heart Failure" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Apollo Speciality Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Apollo Speciality Hospital
Most popular intervention types in "Apollo Speciality Hospital" are "Drug" (18 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Filgotinib" (4 trials), "Placebo" (4 trials), "Dexamethasone" (2 trials), "Empagliflozin" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Apollo Speciality Hospital
The vast majority of trials in "Apollo Speciality Hospital" are
15 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Apollo Speciality Hospital
Currently, there are NaN active trials in "Apollo Speciality Hospital".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 14 completed trials in Apollo Speciality Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Apollo Speciality Hospital, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".